ICHTHYOSIS

Clinical trials for ICHTHYOSIS explained in plain language.

Never miss a new study

Get alerted when new ICHTHYOSIS trials appear

Sign up with your email to follow new studies for ICHTHYOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 2 Terminated 1

Drug trial halted early for rare skin disease

Disease control Terminated

This study tested whether an investigational drug called imsidolimab could safely reduce the severity of ichthyosis, a condition that causes widespread, thick, scaly skin. It was a Phase 2 trial where some participants received the drug and others received a placebo. The trial wa…

Matched conditions: ICHTHYOSIS

Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

ICHTHYOSIS

Get alerted when new ICHTHYOSIS trials appear

Drug trial halted early for rare skin disease